Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Johnson and Johnson
Boehringer Ingelheim
Queensland Health
US Department of Justice
Cipla
McKinsey
Cantor Fitzgerald
US Army
Argus Health

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 9,119,781

« Back to Dashboard

Summary for Patent: 9,119,781
Title:Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid
Abstract: The present invention relates to a topical spray composition comprising a biologically active vitamin D derivative and a corticosteroid, and its use in the treatment of dermal diseases and conditions. The spray comprises especially a propellant selected from the group consisting of dimethyl ether, diethyl ether and methylethyl ether or a mixture thereof and further a pharmaceutically acceptable lipid carrier solubilised or suspended in said propellant.
Inventor(s): Lind; Marianne (Bagsv.ae butted.rd, DK), Rasmussen; Gritt (Virum, DK), Sonne; Mette Rydahl (Brondby Strand, DK), Hansen; Jens (Virum, DK), Petersson; Karsten (Ballerup, DK)
Assignee: LEO PHARMA A/S (Ballerup, DK)
Application Number:13/703,214
Patent Claim Types:
see list of patent claims
Composition; Compound; Use;

Drugs Protected by US Patent 9,119,781

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Leo Pharma As ENSTILAR betamethasone dipropionate; calcipotriene AEROSOL, FOAM;TOPICAL 207589-001 Oct 16, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up Y PLAQUE PSORIASIS ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 9,119,781

PCT Information
PCT FiledJune 10, 2011PCT Application Number:PCT/DK2011/000060
PCT Publication Date:December 15, 2011PCT Publication Number: WO2011/154004

Non-Orange Book US Patents Family Members for Patent 9,119,781

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,566,286 Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 9,119,781

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Russian Federation 2576607 ➤ Sign Up
Russian Federation 2013100996 ➤ Sign Up
Serbia 53809 ➤ Sign Up
Portugal 2579852 ➤ Sign Up
New Zealand 603470 ➤ Sign Up
Mexico 2012013591 ➤ Sign Up
South Korea 101749514 ➤ Sign Up
South Korea 20160054614 ➤ Sign Up
South Korea 101619077 ➤ Sign Up
South Korea 20130109096 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Healthtrust
Cipla
US Army
Dow
Julphar
Boehringer Ingelheim
Teva
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot